JPH0551335A - Cyclic terpene - Google Patents

Cyclic terpene

Info

Publication number
JPH0551335A
JPH0551335A JP21110691A JP21110691A JPH0551335A JP H0551335 A JPH0551335 A JP H0551335A JP 21110691 A JP21110691 A JP 21110691A JP 21110691 A JP21110691 A JP 21110691A JP H0551335 A JPH0551335 A JP H0551335A
Authority
JP
Japan
Prior art keywords
compound
formula
represented
ether
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP21110691A
Other languages
Japanese (ja)
Inventor
Takashi Takahashi
孝志 高橋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Kasei Corp
Original Assignee
Mitsubishi Kasei Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Kasei Corp filed Critical Mitsubishi Kasei Corp
Priority to JP21110691A priority Critical patent/JPH0551335A/en
Publication of JPH0551335A publication Critical patent/JPH0551335A/en
Pending legal-status Critical Current

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

PURPOSE:To provide a new cyclic terpene useful as an intermediate capable of producing an optically active sarcophytol A having anticarcinogenic promoter action and antitumor action in large quantity at a low cost without using highly toxic selenium compound. CONSTITUTION:The compound of formula I [R<1> is H, 1-alkoxyalkyl, SO2R<4> or SiR<5>R<6>R<7>; R<4> to R<7> are 1-4C alkyl or phenyl; R<4> may be phenyl substituted with 1-4C alkyl; R<2> and R<3> are CN or OR<8>; R<2> and R<3> may together form O (when R<1> is SO2R<4>, R<2> and R<3> may together express O); R<8> is H, 1-alkyoxyalkyl or trimethylsilyl], e.g. the compound of formula II. The compound of formula I wherein R<2> and R<3> are CN or OR<8> (R<8> is not H) can be produced by reacting compound of formula III with a base such as lithium diisopropyl amide in a solvent (e.g. tetrahydrofuran) at -70 to +100 deg.C. Sarcophytol A of formula IV can be produced from the above compound on an industrial scale at a low cost.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は新規な環状テルペン類に
関する。詳しくは、本発明の化合物は抗発癌プロモータ
ー作用(Cancer Surveys,,540
(1983);代謝、vol25臨時増刊号 癌 '8
8,3(1988).)及び抗腫瘍作用(特公昭63−
20213号公報)を有するザルコフィトールAまたは
類似の効果の期待されるその立体異性体製造のための重
要な中間体である環状テルペン類に関する。
This invention relates to novel cyclic terpenes. Specifically, the compounds of the present invention have anti-carcinogenic promoter action (Cancer Surveys, 2 , 540).
(1983); Metabolism, vol 25 extra edition Cancer '8
8, 3 (1988). ) And antitumor action (Japanese Patent Publication No. 63-
No. 20213), or cyclic terpenes which are important intermediates for the preparation of sarcophitol A or its stereoisomers with expected similar effects.

【0002】[0002]

【従来の技術及びその課題】下記構造式で表わされるザ
ルコフィトールAは、その14員環中に一つの共役二重
結合を含む計4つの二重結合を有するセンブラン型ジテ
ルペンアルコールである。
2. Description of the Related Art Sarcophytol A represented by the following structural formula is a sembrane type diterpene alcohol having a total of four double bonds including one conjugated double bond in its 14-membered ring.

【0003】[0003]

【化2】 [Chemical 2]

【0004】従来、ザルコフィトールAの合成法は本発
明者らによるものが唯一報告されているのみであった
(特願平3−48633号公報;Tetrahedon
Letters, 31,3317(1990)参
照)。このザルコフィトールAの製造ルートによって、
ザルコフィトールAを工業的に製造しようとする場合、
収率、選択性共に高くない上、毒性の高いセレン化合物
を使用する必要のある末端位メチル基の酸化工程を避け
て通れないという大きな問題があった。
Heretofore, the synthesis method of sarcophytol A was reported only by the present inventors (Japanese Patent Application No. 3-48633; Tetrahedon).
Letters, 31 , 3317 (1990)). By the manufacturing route of this Zarcophytol A,
When trying to industrially produce Zarcophytol A,
There is a big problem that the yield and the selectivity are not high and the oxidization process of the terminal methyl group which requires the use of a highly toxic selenium compound cannot be avoided.

【0005】[0005]

【課題を解決するための手段】本発明者らは、工業的に
より有利な方法によって光学活性ザルコフィトールAを
大量かつ安価に製造、供給することを目的として鋭意検
討した結果、本発明の環状テルペン類が上記の問題点を
解決できる新規な製造ルートにおける有用な中間体であ
ることを見い出し本発明に到達した。即ち、本発明の要
旨は、下記一般式(I)
DISCLOSURE OF THE INVENTION As a result of intensive investigations by the present inventors for the purpose of producing and supplying a large amount of an optically active sarcophytol A by an industrially more advantageous method and at a low cost, the ring of the present invention was obtained. The present inventors have found that terpenes are useful intermediates in a novel production route that can solve the above problems, and arrived at the present invention. That is, the gist of the present invention is the following general formula (I)

【0006】[0006]

【化3】 [Chemical 3]

【0007】〔上記一般式(I)中で、R1 は水素原
子、1−アルコキシアルキル基、−SO 2 4 (R4
炭素数1〜4のアルキル基または炭素数1〜4のアルキ
ル基で置換されていても良いフェニル基を表す。)また
は−SiR5 6 7 (R5 ,R 6 およびR7 はそれぞ
れ独立して炭素数1〜4のアルキル基またはフェニル基
を表す。)を表し、R2 およびR3 はそれぞれ独立して
−CNまたは−OR8 (R 8 は水素原子、1−アルコキ
シアルキル基またはトリメチルシリル基を表す。)を表
すが、R2 およびR3 が一緒になって酸素原子を表して
もよい。なお、R1 が−SO2 4 を表すときは、R2
およびR3 は一緒になって酸素原子を表す。〕で表され
る環状テルペン類に存する。
[In the above general formula (I), R1Is hydrogen
Child, 1-alkoxyalkyl group, -SO 2RFour(RFourIs
An alkyl group having 1 to 4 carbon atoms or an alkyl group having 1 to 4 carbon atoms
Represents a phenyl group which may be substituted with a ru group. )Also
Is -SiRFiveR6R7(RFive, R 6And R7Is that
Independently, an alkyl group having 1 to 4 carbon atoms or a phenyl group
Represents ), R2And R3Each independently
-CN or -OR8(R 8Is a hydrogen atom, 1-alkoxy
Represents a silyl group or a trimethylsilyl group. ) Table
But R2And R3Together represent the oxygen atom
Good. In addition, R1Is -SO2RFourTo represent R2
And R3Together represent an oxygen atom. ]]
It exists in cyclic terpenes.

【0008】以下本発明につき詳細に説明する。上記の
定義においてR1の示す1−アルコキシアルキル基とし
てはメトキシメチル基、1−エトキシエチル基、1−n
−プロポキシエチル基などが挙げられ、基−SO2 4
としては−SO2 CH3 ,−SO22 5 ,−SO2
Ph(Phはフェニル基を表す。)、−SO2 pTol
(pTolはパラトリル基を表す。)などが挙げられ、
基−SiR5 6 4 としてはt−ブチルジメチルシリ
ル基、ジメチルフェニルシリル基、t−ブチルジフェニ
ルシリル基などが挙げられる。
The present invention will be described in detail below. In the above definition, the 1 -alkoxyalkyl group represented by R 1 is methoxymethyl group, 1-ethoxyethyl group, 1-n
-Propoxyethyl group and the like, and the group -SO 2 R 4
The -SO 2 CH 3, -SO 2 C 2 H 5, -SO 2
Ph (Ph represents a phenyl group.), - SO 2 pTol
(PTol represents a paratolyl group) and the like,
Examples of the group —SiR 5 R 6 R 4 include t-butyldimethylsilyl group, dimethylphenylsilyl group, t-butyldiphenylsilyl group and the like.

【0009】上記の定義においてR2 あるいはR3 の示
す基−OR8 のR8 が示す1−アルコキシアルキル基と
しては1−エトキシエチル基、1−n−プロポキシエチ
ル基などが挙げられる。以下に上記一般式(I)で表わ
される好ましい化合物の具体例を示す。 (1)R2 およびR3 がCNまたはOR8 (R8 は1−
アルコキシアルキル基又はトリメチルシリル基を表
す。)を表す場合。
In the above definition, the 1-alkoxyalkyl group represented by R 8 of the group —OR 8 represented by R 2 or R 3 includes 1-ethoxyethyl group, 1-n-propoxyethyl group and the like. Specific examples of preferred compounds represented by the above general formula (I) are shown below. (1) R 2 and R 3 are CN or OR 8 (R 8 is 1-
It represents an alkoxyalkyl group or a trimethylsilyl group. ) Is represented.

【0010】[0010]

【化4】 [Chemical 4]

【0011】[0011]

【表1】 [Table 1]

【0012】(2)R2 およびR3 がCNまたはOR8
(R8 は水素原子を表す。)を表す場合。
(2) R 2 and R 3 are CN or OR 8
When R 8 represents a hydrogen atom.

【0013】[0013]

【化5】 [Chemical 5]

【0014】[0014]

【表2】 [Table 2]

【0015】(3)R2 およびR3 が一緒になって酸素
原子を表す場合。
(3) When R 2 and R 3 together represent an oxygen atom.

【0016】[0016]

【化6】 [Chemical 6]

【0017】[0017]

【表3】 [Table 3]

【0018】(Meはメチル基を、Buはブチル基をそ
れぞれ表す) 次に本発明の化合物の製法について説明する。上記一般
式(I)で表される化合物は、たとえば下記一般式
(A)
(Me represents a methyl group and Bu represents a butyl group) Next, a method for producing the compound of the present invention will be described. The compound represented by the general formula (I) is, for example, the following general formula (A)

【0019】[0019]

【化7】 [Chemical 7]

【0020】(上記一般式(A)中、R1 およびR8
既に定義した通りである。ただし、R 8 は水素原子を表
さない。)で表される鎖状前駆体(製造法は後述す
る。)から製造できる。すなわち、上記一般式(A)で
表わされる化合物から、たとえばエチルエーテル、テト
ラヒドロフラン等のエーテル系溶媒、ベンゼン、トルエ
ン等の芳香族炭化水素系溶媒またはn−ヘキサン、n−
ヘプタン等の飽和炭化水素系溶媒中、1〜10当量のリ
チウムジイソプロピルアミド、リチウムビス(トリメチ
ルシリル)アミド、水素化ナトリウムなどの塩基を、−
70〜100℃で、5分〜10時間作用させる方法など
により上記一般式(I)においてR2 およびR 3 がCN
またはOR8 (R8 は水素原子を表さない。)を表す化
合物を製造できるし、テトラヒドロフラン、メタノール
などの溶媒中、0.1〜3規定の塩酸、硫酸等の鉱酸水
溶液を0℃〜室温で、5分〜5時間作用させる方法、ま
たはテトラヒドロフラン、ジオキサン等の溶媒中、−2
0℃〜室温で、1〜10当量のフッ化テトラブチルアン
モニウム等のテトラアルキルアンモニウム類を作用させ
る方法などにより上記一般式(I)においてR2 および
3 がCNまたはOHを示す化合物を製造できる。次い
で、上記化合物のエチルエーテル、酢酸エチル等の有機
溶媒の溶液を炭酸水素ナトリウム水溶液、または水酸化
ナトリウム水溶液に0℃〜室温で5分〜5時間作用させ
る方法などにより、あるいは上記一般式(I)において
2 およびR3 がCNまたはOR8 (R8 は水素原子を
表さない。)で表わされる化合物より、含水テトラヒド
ロフラン、ジオキサン等の溶媒中、1〜10当量のフッ
化テトラブチルアンモニウム等のフッ化アルキルアンモ
ニウム類を上記化合物に作用させる方法等により直接上
記一般式(I)においてR2 およびR3 が一緒になって
酸素原子を表す化合物を製造できる。
(In the above general formula (A), R1And R8Is
As defined above. However, R 8Represents a hydrogen atom
I don't. A chain-like precursor represented by
It ) Can be manufactured from. That is, in the above general formula (A)
From the compounds represented, for example, ethyl ether, tet
Ethereal solvents such as lahydrofuran, benzene, and toluene
Aromatic hydrocarbon solvents such as benzene, n-hexane, n-
In a saturated hydrocarbon solvent such as heptane, 1 to 10 equivalents of
Thallium diisopropylamide, lithium bis (trimethyl
Base, such as rusilyl) amide, sodium hydride,
A method of operating at 70 to 100 ° C for 5 minutes to 10 hours, etc.
In the general formula (I)2And R 3Is CN
Or OR8(R8Does not represent a hydrogen atom. ) Represents
Compound can be produced, tetrahydrofuran, methanol
0.1-3 normal hydrochloric acid, sulfuric acid, and other mineral acid water in a solvent such as
The method of allowing the solution to act at 0 ° C to room temperature for 5 minutes to 5 hours, or
Or in a solvent such as tetrahydrofuran or dioxane, -2
At 0 ° C to room temperature, 1 to 10 equivalents of tetrabutylan fluoride
Acting on tetraalkylammoniums such as monium
R in the above general formula (I)2and
R3A compound can be prepared wherein CN represents CN or OH. Next
And organic compounds such as ethyl ether and ethyl acetate of the above compounds.
Solvent solution is sodium hydrogen carbonate solution or hydroxylated
Let the aqueous solution of sodium act at 0 ° C to room temperature for 5 minutes to 5 hours.
Or in the above general formula (I)
R2And R3Is CN or OR8(R8Is a hydrogen atom
Not represented. ) From the compound represented by
1 to 10 equivalents of fluorine in a solvent such as lofuran or dioxane
Alkylammonium fluoride such as tetrabutylammonium fluoride
Directly using a method such as reacting the above-mentioned compounds with nickel
In the general formula (I), R2And R3Together
Compounds representing oxygen atoms can be prepared.

【0021】上記一般式(I)においてR1 が水素原
子、R2 およびR3 が一緒になって酸素原子を表す化合
物から出発して、たとえば、ジクロロメタン、クロロホ
ルム等のハロゲン系溶媒又はジエチルエーテル、テトラ
ヒドロフラン等のエーテル系溶媒中、0.1〜10当量
のトリエチルアミン、ピリジン等の塩基存在下、0.1
〜1.5当量の塩化メタンスルホニル、塩化パラトルエ
ンスルホニル等のハロゲン化置換スルホニルを−70〜
100℃で上記化合物に作用させるなどの方法により、
上記一般式(I)においてR1 が−SO 24 であり、
2 およびR3 が一緒になって酸素原子を表す化合物を
製造できる。
Starting from a compound in which R 1 represents a hydrogen atom and R 2 and R 3 together represent an oxygen atom in the above general formula (I), for example, a halogen-based solvent such as dichloromethane or chloroform, or diethyl ether, In an ether solvent such as tetrahydrofuran, 0.1 to 10 equivalents of triethylamine, pyridine and the like in the presence of a base of 0.1
~ 1.5 equivalents of a halogenated substituted sulfonyl such as methanesulfonyl chloride, paratoluenesulfonyl chloride, etc.
By a method such as acting on the above compound at 100 ° C.,
In the above general formula (I), R 1 is —SO 2 R 4 ,
A compound in which R 2 and R 3 together represent an oxygen atom can be prepared.

【0022】上記一般式(A)で表わされる化合物はた
とえば文献(J.Org.Chem.,52,3860
(1987))に記載された下記化合物(B)を出発原
料として下記の合成ルートに従って製造できる。
The compound represented by the above general formula (A) is disclosed in, for example, the literature (J. Org. Chem., 52 , 3860).
The compound (B) described in (1987)) can be used as a starting material according to the following synthetic route.

【0023】[0023]

【化8】 [Chemical 8]

【0024】(上記式中、Acはアセチル基を表し、X
はハロゲン原子を表し、R1 およびR 8 は上記一般式
(I)中で定義した通りである。ただし、R8 は水素原
子を表さない。)すなわち、上記化合物(B)にメタノ
ール、エタノール等の溶媒中、1〜2当量の金属アルコ
キシドを−50〜50℃にて作用させるエステル交換の
方法、メタノール、エタノール、テトラヒドロフラン等
の溶媒中0.5〜10当量の水酸化ナトリウム、水酸化
カリウム等の水溶液または粉末炭酸カリウムなどを−5
0〜50℃にて作用させる加水分解の方法、ジエチルエ
ーテル、テトラヒドロフラン、n−ヘキサン、トルエン
等の溶媒中−70〜50℃にて0.5〜10当量の水素
化アルミニウムリチウム等の金属水素錯化合物または水
素化ジイソブチルアルミニウム等の金属水素化物を作用
させる還元反応による方法などにより上記化合物(C)
を製造できる。
(In the above formula, Ac represents an acetyl group, X
Represents a halogen atom, R1And R 8Is the above general formula
As defined in (I). However, R8Is hydrogen
Does not represent a child. ) That is, methano is added to the above compound (B).
1 to 2 equivalents of metal alcohol in a solvent such as ethanol or ethanol.
Of transesterification with oxidant at -50 to 50 ° C
Method, methanol, ethanol, tetrahydrofuran, etc.
0.5 to 10 equivalents of sodium hydroxide in a solvent of
An aqueous solution of potassium or the like or powdered potassium carbonate or the like -5
The method of hydrolysis that works at 0-50 ° C, diethyl ether
Ether, tetrahydrofuran, n-hexane, toluene
0.5 to 10 equivalents of hydrogen at -70 to 50 ° C in a solvent such as
Metal-hydrogen complex compound such as lithium aluminum fluoride or water
Works with metal hydrides such as diisobutylaluminum
The compound (C) is prepared by a method such as a reduction reaction
Can be manufactured.

【0025】上記化合物(C)に、塩化メチレン、クロ
ロホルム等のハロゲン系溶媒、ヘキサン、ヘプタン等の
炭化水素系溶媒またはエチルエーテル、酢酸エチル等の
溶媒中、重量比で5〜20倍の粉末二酸化マンガン、マ
ンガン酸バリウム等の酸化剤を−50〜50℃で、1〜
50時間作用させる方法などにより上記化合物(D)を
製造できる。
The above compound (C) is mixed with a halogen-based solvent such as methylene chloride or chloroform, a hydrocarbon-based solvent such as hexane or heptane, or a solvent such as ethyl ether or ethyl acetate in a weight ratio of 5 to 20 times as much as powdered dioxide. Oxidizing agents such as manganese and barium manganate at -50 to 50 ° C for 1 to
The compound (D) can be produced by a method of allowing it to act for 50 hours.

【0026】下記式The following formula

【0027】[0027]

【化9】 [Chemical 9]

【0028】で表される既知の2−ブロモ−2−ブテナ
ールのアセタールに、ジエチルエーテル、テトラヒドロ
フラン等のエーテル系溶媒中、−100〜50℃で、
0.1〜1.2当量のn−ブチルリチウム、i−ブチル
リチウムなどの有機金属を加えることにより上記化合物
(E)が製造できる。これに上記の方法で製造される上
記化合物を(D)を−100〜50℃で作用させたもの
を加水分解すると上記化合物(F)を製造できる。
To a known 2-bromo-2-butenal acetal represented by the following formula, in an ether solvent such as diethyl ether or tetrahydrofuran at -100 to 50 ° C,
The above compound (E) can be produced by adding 0.1 to 1.2 equivalents of an organic metal such as n-butyllithium or i-butyllithium. The compound (F) can be produced by hydrolyzing the compound produced by the above method produced by reacting the compound (D) at -100 to 50 ° C.

【0029】上記した製造方法で製造した化合物(F)
に、塩化メチレン、クロロホルム等のハロゲン系溶媒、
ジエチルエーテル、テトラヒドロフラン等のエーテル系
溶媒または酢酸エチル等の溶媒中、触媒としての塩酸、
硫酸等の鉱酸、パラトルエンスルホン酸、カンファース
ルホン酸等の有機スルホン酸あるいはパラトルエンスル
ホン酸のピリジニウム塩等の強酸の塩の存在下、0.5
〜10当量のエチルビニルエーテル、ジヒドロピラン等
のビニルエーテル類を−20〜100℃にて作用させる
方法、または−20〜100℃で0.5〜10当量のク
ロロメチルメチルエーテル、クロロメチル−2−メトキ
シエチルエーテル等の1−ハロアルキルエーテル類を、
テトラヒドロフラン、ジエチルエーテル、ジメチルホル
ムアミド等の溶媒中、あるいは無溶媒で、0.5〜10
当量の水素化ナトリウム、水素化カリウム等の金属水素
化物、トリエチルアミン、、ピリジン、ジイソプロピル
アミン等のアミン類などを塩基として共に作用させる方
法、または0.1〜10当量のトリメチルクロロシラ
ン、ジメチル−t−ブチルクロロシラン等のクロロシラ
ン類を塩化メチレン、クロロホルム等のハロゲン系溶
媒、ヘキサン、ベンゼン等の炭化水素系溶媒、ジエチル
エーテル、テトラヒドロフラン等のエーテル系溶媒また
は酢酸エチル、ジメチルホルムアミド、ジメチルスルホ
キシド等の非プロトン性極性溶媒中、0.1〜10当量
のトリエチルアミン、、ジメチルアミノピリジン、イミ
ダゾール等の含窒素化合物、あるいは水素化ナトリウ
ム、水素化カリウム等の金属水素化物を塩基として−2
0〜100℃で5分〜24時間共に作用させる方法によ
り上記化合物(G)を製造できる。
Compound (F) produced by the above production method
A halogen-based solvent such as methylene chloride or chloroform,
Hydrochloric acid as a catalyst in an ether solvent such as diethyl ether or tetrahydrofuran, or a solvent such as ethyl acetate,
0.5 in the presence of a mineral acid such as sulfuric acid, an organic sulfonic acid such as paratoluenesulfonic acid, camphorsulfonic acid, or a strong acid salt such as a pyridinium salt of paratoluenesulfonic acid.
10 to 10 equivalents of vinyl ethers such as ethyl vinyl ether and dihydropyran are allowed to act at -20 to 100 ° C, or 0.5 to 10 equivalents of chloromethyl methyl ether and chloromethyl-2-methoxy at -20 to 100 ° C. 1-haloalkyl ethers such as ethyl ether,
0.5-10 in a solvent such as tetrahydrofuran, diethyl ether, dimethylformamide or without solvent
A method in which equivalent amounts of metal hydrides such as sodium hydride and potassium hydride, amines such as triethylamine, pyridine and diisopropylamine are allowed to act together as a base, or 0.1 to 10 equivalents of trimethylchlorosilane and dimethyl-t- Chlorosilanes such as butylchlorosilane are halogenated solvents such as methylene chloride and chloroform, hydrocarbon solvents such as hexane and benzene, ether solvents such as diethyl ether and tetrahydrofuran, or aprotic substances such as ethyl acetate, dimethylformamide and dimethyl sulfoxide. In a polar solvent, 0.1 to 10 equivalents of triethylamine, a nitrogen-containing compound such as dimethylaminopyridine and imidazole, or a metal hydride such as sodium hydride and potassium hydride as a base-2
The said compound (G) can be manufactured by the method of making it work for 5 minutes-24 hours at 0-100 degreeC.

【0030】上記の方法で製造した化合物(G)にテト
ラヒドロフラン、メタノール、エタノール等の溶媒中、
0.1〜3当量の塩酸、硫酸等の鉱酸水溶液を0℃〜室
温で5分〜24時間作用させるなどの方法により上記化
合物(H)を製造できる。上記化合物(H)のR1 が1
−アルコキシアルキル基である場合には1−アルコキシ
アルキル基のあるものは加水分解され、R1 =水素原子
である化合物を与える。
Compound (G) produced by the above method was added to a solvent such as tetrahydrofuran, methanol or ethanol,
The compound (H) can be produced by a method of reacting 0.1 to 3 equivalents of an aqueous mineral acid solution such as hydrochloric acid or sulfuric acid at 0 ° C. to room temperature for 5 minutes to 24 hours. R 1 of the above compound (H) is 1
- when it is alkoxyalkyl group certain of 1-alkoxyalkyl group is hydrolyzed, to give the compound a R 1 = hydrogen atom.

【0031】上記の方法で製造した化合物(H)に塩化
メチレン、クロロホルム、酢酸エチルなどの溶媒中また
は無溶媒で、1〜10当量のトリメチルシリルニトリル
を触媒としてのシアン化金属−18−クラウン−6−エ
ーテル錯体の存在下で、−20〜50℃で、30分〜5
時間作用させる方法などにより上記一般式(A)中のR
8 =トリメチルシリル基で表される化合物を製造でき
る。この化合物をテトラヒドロフラン、メタノール等の
溶媒に溶解後、0.1〜3当量の塩酸、硫酸等の鉱酸水
溶液を0℃〜室温で、5分〜5時間作用させる方法、又
はテトラヒドロフラン、ジオキサン等の溶媒中、−20
℃〜室温で1〜10当量のフッ化テトラブチルアンモニ
ウム等のテトラアルキルアンモニウム類を作用させる方
法などによってR8 =水素原子で表される上記化合物
(A)(シアノヒドリン体)を製造できる。R8 =1−
アルコキシアルキル基で表される上記一般式(A)で表
される化合物は、上記シアノヒドリン体に、エチルエー
テル、酢酸エチル等の溶媒中1〜10当量のエチルビニ
ルエーテル等を触媒としての塩酸、硫酸などの鉱酸、パ
ラトルエンスルホン酸などの有機強酸あるいはパラトル
エンスルホン酸のピリジニウム塩などの強酸の塩の存在
下、−20℃〜室温で、30分〜5時間作用させるなど
の方法により製造できる。
Metal cyanide-18-crown-6 with 1 to 10 equivalents of trimethylsilylnitrile as a catalyst in the compound (H) produced by the above method in a solvent such as methylene chloride, chloroform, ethyl acetate or without solvent. -In the presence of an ether complex, at -20 to 50 ° C for 30 minutes to 5
R in the general formula (A) may be changed depending on the method of acting for a time.
A compound represented by 8 = trimethylsilyl group can be produced. After dissolving this compound in a solvent such as tetrahydrofuran or methanol, a method of reacting 0.1 to 3 equivalents of an aqueous solution of a mineral acid such as hydrochloric acid or sulfuric acid at 0 ° C. to room temperature for 5 minutes to 5 hours, or a method such as tetrahydrofuran or dioxane is used. -20 in solvent
The compound (A) (cyanohydrin form) represented by R 8 = hydrogen atom can be produced by a method of reacting 1 to 10 equivalents of a tetraalkylammonium such as tetrabutylammonium fluoride at a temperature of room temperature to room temperature. R 8 = 1-
The compound represented by the above general formula (A) represented by an alkoxyalkyl group is hydrochloric acid, sulfuric acid or the like using 1 to 10 equivalents of ethyl vinyl ether or the like in a solvent such as ethyl ether or ethyl acetate as a catalyst to the cyanohydrin compound. In the presence of a mineral acid, an organic strong acid such as p-toluenesulfonic acid, or a salt of a strong acid such as a pyridinium salt of p-toluenesulfonic acid at -20 ° C to room temperature for 30 minutes to 5 hours.

【0032】上記一般式(A)で表される化合物から本
発明の上記一般式(I)で表される化合物の製造につい
ては既に述べた通りである。本発明の上記一般式(I)
で表される化合物からたとえば下記の合成ルートにより
上述した既存の製造法の有する問題点のないザルコフィ
トールAを製造できる。
The production of the compound represented by the above general formula (I) of the present invention from the compound represented by the above general formula (A) is as described above. The above general formula (I) of the present invention
From the compound represented by, for example, sarcophytol A can be produced by the following synthetic route, which does not have the problems of the above-mentioned existing production methods.

【0033】[0033]

【化10】 [Chemical 10]

【0034】(上記式中、R1 は既に定義した通りであ
る。)すなわち、たとえば上記一般式(I)で表される
化合物のうち、R2 およびR 3 が一緒になって酸素原子
を表す化合物から、たとえば0.5〜10当量のジメチ
ル銅リチウムを−100℃〜室温でジエチルエーテル、
テトラヒドロフラン等のエーテル系溶媒中作用させる方
法などにより上記化合物(J)を製造でき、これにエチ
ルエーテル、テトラヒドロフラン等のエーテル系溶媒、
ベンゼン、トルエン等の芳香族炭化水素系溶媒又はn−
ヘキサン、n−ヘプタン等の飽和炭化水素系溶媒中−7
0〜50℃で、水素化ジブチルアルミニウム等の金属水
素化物、水素化アルミニウムリチウム等の金属錯化合物
を1〜10当量、5分〜5時間作用させる方法などによ
りザルコフィトールAを製造できる。
(In the above formula, R1As already defined
It ) That is, for example, represented by the above general formula (I)
Of the compounds, R2And R 3Together with oxygen atom
From the compound represented by
Lithium copper in diethyl ether at -100 ℃ ~ room temperature,
Those acting in an ether solvent such as tetrahydrofuran
The above compound (J) can be produced by a method such as
Ether solvents such as ruthel and tetrahydrofuran,
Aromatic hydrocarbon solvents such as benzene and toluene, or n-
-7 in a saturated hydrocarbon solvent such as hexane or n-heptane
Metal water such as dibutylaluminum hydride at 0 to 50 ° C
Metal complex compounds such as halides and lithium aluminum hydride
1 to 10 equivalents for 5 minutes to 5 hours
It is possible to produce sarcophytol A.

【0035】以上述べた通り、本発明の化合物を中間体
とするザルコフィトールAの合成ルートはザルコフィト
ールAの製造のための工業上優れたルートであり、従っ
て本発明の化合物はその目的のために極めて重要な合成
中間体である。
As described above, the synthetic route of sarcophytol A using the compound of the present invention as an intermediate is an industrially excellent route for producing sarcophytol A, and therefore the compound of the present invention has its object. Is a very important synthetic intermediate.

【0036】[0036]

【実施例】以下に実施例を挙げて本発明を更に詳しく説
明するが、本発明はその要旨を超えない限り、以下の実
施例により限定を受けるものではない。 合成例1
The present invention will be described in more detail with reference to the following examples, but the present invention is not limited to the following examples unless it exceeds the gist. Synthesis example 1

【0037】[0037]

【化11】 [Chemical 11]

【0038】上記(1)式で表されるアルコール体
〔J.Org.Chem.,51巻22号、4316−
4319項(1986)に記載〕(4.55g)をCH
3 CN(50ml)に溶解し、トリフェニルホスフィン
(5.5g)を加えた。0℃冷却下、CBr4 (7g)
を3回に分け、5分ごとに加えた。反応の完結を確認し
た後、濃縮し、ヘキサンを加え、充分撹拌し、セライト
でろ過、濃縮後得られた残渣をシリカゲルカラムクロマ
トグラフィー(展開溶媒、ヘキサン:エチルエーテル=
98:2)にて精製し、目的とする上記(2)式で表さ
れる化合物(7g)を合成した。
The alcohol compound represented by the above formula (1) [J. Org. Chem. 51, No. 22, 4316-
Item 4319 (1986)] (4.55 g)
It was dissolved in 3 CN (50 ml) and triphenylphosphine (5.5 g) was added. CBr 4 (7g) under cooling at 0 ° C
Was added in 3 portions and added every 5 minutes. After confirming the completion of the reaction, the mixture was concentrated, hexane was added, the mixture was stirred well, filtered through Celite, and the residue obtained after concentration was subjected to silica gel column chromatography (developing solvent, hexane: ethyl ether =
98: 2), and the desired compound (7 g) represented by the above formula (2) was synthesized.

【0039】 1H−NMR(90MHz) δ=1.58(s,3H) 1.70(s,3H) 1.74(s,3H) 2.05(brs,11H) 3.96(s,2H) 4.58(d,J=7.03Hz,2H) 5.09(m,1H) 5.33(m,1H) 5.56(m,1H) 合成例2 1 H-NMR (90 MHz) δ = 1.58 (s, 3H) 1.70 (s, 3H) 1.74 (s, 3H) 2.05 (brs, 11H) 3.96 (s, 2H) 4.58 (d, J = 7.03 Hz, 2H) 5.09 (m, 1H) 5.33 (m, 1H) 5.56 (m, 1H) Synthesis example 2

【0040】[0040]

【化12】 [Chemical formula 12]

【0041】上記(2)式で表されるアセテート(7
g)をメタノール(100ml)に溶解し、0℃冷却下
2 CO3 (6.7g)加え充分撹拌した。1時間後、
反応の完結を確認し、水、飽和食塩水で洗浄した後、エ
ーテル層を分離し、無水硫酸マグネシウムで乾燥し、濃
縮して得た残渣をシリカゲルカラムクロマトグラフィー
(展開溶媒、ヘキサン:エチルエーテル=1:1)にて
精製し、目的とする上記(3)式で表される化合物
(7.37g)を合成した。
Acetate (7) represented by the above formula (2)
g) was dissolved in methanol (100 ml), K 2 CO 3 (6.7 g) was added under cooling at 0 ° C., and the mixture was sufficiently stirred. One hour later,
After confirming the completion of the reaction and washing with water and saturated saline, the ether layer was separated, dried over anhydrous magnesium sulfate, and concentrated to obtain a residue, which was subjected to silica gel column chromatography (developing solvent, hexane: ethyl ether = The compound (7.37 g) represented by the above formula (3) was synthesized.

【0042】 1H−NMR(90MHz) δ=1.60(s,3H) 1.67(s,3H) 1.74(s,3H) 2.05(brs,8H) 3.97(s,2H) 4.15(d,J=6.81Hz,2H) 5.10(m,1H) 5.40(m,1H) 5.56(m,1H) 合成例3 1 H-NMR (90 MHz) δ = 1.60 (s, 3H) 1.67 (s, 3H) 1.74 (s, 3H) 2.05 (brs, 8H) 3.97 (s, 2H) 4.15 (d, J = 6.81 Hz, 2H) 5.10 (m, 1H) 5.40 (m, 1H) 5.56 (m, 1H) Synthesis example 3

【0043】[0043]

【化13】 [Chemical 13]

【0044】上記(3)式で表されるヒドロキシブロム
体(7.37g)をベンゼン(1ml)と塩化メチレン
(1ml)の混合液に溶解し、二酸化マンガン(14
g)を少しずつ加え、室温で20時間撹拌した。反応の
完結を確認した後セライトでろ過し、濃縮して得た残渣
をシリカゲルカラムクロマトグラフィー(展開溶媒、ヘ
キサン:エチルエーテル=98:2)にて精製し、目的
とする上記(4)式で表される化合物(1.86g、合
計収率38%)を合成した。
The hydroxybromine derivative (7.37 g) represented by the above formula (3) was dissolved in a mixed solution of benzene (1 ml) and methylene chloride (1 ml), and manganese dioxide (14
g) was added little by little, and the mixture was stirred at room temperature for 20 hours. After confirming the completion of the reaction, the residue obtained by filtering through Celite and concentrating was purified by silica gel column chromatography (developing solvent, hexane: ethyl ether = 98: 2), and the desired formula (4) was used. The represented compound (1.86 g, total yield 38%) was synthesized.

【0045】 1H−NMR(90MHz) δ=1.60(s,3H) 1.74(s,3H) 2.05(brs,11H) 3.95(s,2H) 5.08(brs,1H) 5.56(brs,1H) 5.80(brs,1H) 9.97(d,J=7.91Hz,1H) 合成例4 1 H-NMR (90 MHz) δ = 1.60 (s, 3 H) 1.74 (s, 3 H) 2.05 (brs, 11 H) 3.95 (s, 2 H) 5.08 (brs, 1H) 5.56 (brs, 1H) 5.80 (brs, 1H) 9.97 (d, J = 7.91 Hz, 1H) Synthesis example 4

【0046】[0046]

【化14】 [Chemical 14]

【0047】上記(5)式で表されるクロトンアルデヒ
ド(10ml)を塩化メチレン(45ml)に溶解し、
ヒドロキノン(50ml)を加えた後、0℃冷却下臭素
(6.2ml)を塩化メチレン(45ml)に溶解した
ものを6時間かけてゆっくり滴下した。これに0℃冷却
下で酢酸カリウム(17.8g)を加え、室温で一晩静
置した。これにエーテルを加え、水と飽和食塩水で洗浄
し、エーテル層を分離し、無水硫酸マグネシウムで乾燥
後、濃縮して目的とする上記(6)式で表される化合物
(17g)を合成した。
The crotonaldehyde (10 ml) represented by the above formula (5) was dissolved in methylene chloride (45 ml),
After adding hydroquinone (50 ml), a solution of bromine (6.2 ml) dissolved in methylene chloride (45 ml) was slowly added dropwise over 6 hours under cooling at 0 ° C. Potassium acetate (17.8 g) was added to this under cooling at 0 ° C., and the mixture was allowed to stand at room temperature overnight. Ether was added to this, washed with water and saturated saline, the ether layer was separated, dried over anhydrous magnesium sulfate, and concentrated to synthesize the desired compound (17 g) represented by the above formula (6). ..

【0048】 1H−NMR(90MHz) δ=2.15(d,J=6.48Hz,3H) 7.20(d,J=6.48Hz,1H) 9.21(s,J H) 合成例5 1 H-NMR (90 MHz) δ = 2.15 (d, J = 6.48 Hz, 3 H) 7.20 (d, J = 6.48 Hz, 1 H) 9.21 (s, J H) Synthesis Example 5

【0049】[0049]

【化15】 [Chemical 15]

【0050】上記(6)式で表されるホルミル体(17
g)をエタノール(100ml)に溶解し、(C2 5
O)3 CH(24ml)、パラトルエンスルホン酸を少
量加え室温で撹拌した。15時間後、エーテルで希釈
し、水、水性NaHCO3 、飽和食塩水の順に洗浄した
後エーテル層を分離し、無水硫酸マグネシウムで乾燥し
た。これを濃縮した後、減圧蒸留(49〜53℃/3m
mHg)により目的とする上記(7)式で表される化合
物(15.31g、合計収率57%)を合成した。
Formyl body (17) represented by the above formula (6)
g) is dissolved in ethanol (100 ml), and (C 2 H 5
O) 3 CH (24 ml) and paratoluenesulfonic acid were added in small amounts, and the mixture was stirred at room temperature. After 15 hours, the mixture was diluted with ether, washed with water, aqueous NaHCO 3 , and saturated saline in this order, and then the ether layer was separated and dried over anhydrous magnesium sulfate. After concentrating this, vacuum distillation (49-53 ° C / 3m
The target compound (15.31 g, total yield 57%) represented by the above formula (7) was synthesized with mHg).

【0051】 1H−NMR(90MHz) δ=1.31(t,J=7.03Hz,6H) 1.50(dd,J=0.88Hz,J=6.59Hz,3H) 3.55(ABXm,4H) 4.78(brs,1H) 6.30(dq,J=0.88Hz,J=6.59Hz,1H) 合成例6 1 H-NMR (90 MHz) δ = 1.31 (t, J = 7.03 Hz, 6 H) 1.50 (dd, J = 0.88 Hz, J = 6.59 Hz, 3 H) 3.55 ( ABXm, 4H) 4.78 (brs, 1H) 6.30 (dq, J = 0.88 Hz, J = 6.59 Hz, 1H) Synthesis example 6

【0052】[0052]

【化16】 [Chemical 16]

【0053】アルゴン雰囲気下、上記(7)式で表され
るアセタール(1.26g)にヘキサン(15ml)を
加え、−78℃冷却下ノルマルブチルリチウム(1.8
5ml、1.1当量)を徐々に加えた。その後−40℃
まで昇温し、1時間後アセタールがなくなっていること
をガスクロマトグラフィーで確認した後、−78℃に冷
却し、上記(4)式で表されるホルミル体(843m
g)をテトラヒドロフラン(2ml)に溶解したものを
ゆっくり滴下した。30分後−78℃冷却下水性NH4
Clによりクエンチした後エーテルで抽出した。これを
飽和食塩水で洗浄し、エーテル層を分離し、無水硫酸マ
グネシウムで乾燥後、濃縮して得た残渣をシリカゲルカ
ラムクロマトグラフィ−(展開溶媒、ヘキサン:エチル
エーテル=98:2)にて精製し、目的とする上記
(9)式で表される化合物(973.2mg)を合成し
た。
Under an argon atmosphere, hexane (15 ml) was added to the acetal (1.26 g) represented by the above formula (7), and normal butyl lithium (1.8) was added under cooling at -78 ° C.
5 ml, 1.1 eq) was added slowly. Then -40 ℃
The temperature was raised to 1 hour, and after 1 hour, it was confirmed by gas chromatography that the acetal had disappeared, then the mixture was cooled to -78 ° C, and the formyl body (843 m) represented by the above formula (4) was obtained.
What melt | dissolved g) in tetrahydrofuran (2 ml) was dripped slowly. 30 minutes later-78 ° C under cooling aqueous NH 4
After quenching with Cl, it was extracted with ether. This was washed with saturated brine, the ether layer was separated, dried over anhydrous magnesium sulfate, and concentrated to give a residue, which was purified by silica gel column chromatography (developing solvent, hexane: ethyl ether = 98: 2). A target compound (973.2 mg) represented by the above formula (9) was synthesized.

【0054】 1H−NMR(90MHz) δ=1.10〜1.40(m,6H) 1.58(s,6H) 1.68(s,3H) 1.77(d,J=6.30Hz,3H) 2.05〜2.20(brm,8H) 3.20〜3.80(m,4H) 3.97(s,2H) 4.90(brs,1H) 5.00〜5.60(m,4H) 5.68(q,J=6.30Hz,1H) 合成例7 1 H-NMR (90 MHz) δ = 1.10 to 1.40 (m, 6H) 1.58 (s, 6H) 1.68 (s, 3H) 1.77 (d, J = 6. 30 Hz, 3H) 2.05 to 2.20 (brm, 8H) 3.20 to 3.80 (m, 4H) 3.97 (s, 2H) 4.90 (brs, 1H) 5.00 to 5. 60 (m, 4H) 5.68 (q, J = 6.30Hz, 1H) Synthesis example 7

【0055】[0055]

【化17】 [Chemical 17]

【0056】上記(10)式で表されるアルコール(9
73.2mg)を塩化メチレン(1.2ml)に溶解
し、0℃、アルゴン雰囲気下ジイソプロピルエチルアミ
ン(1.53ml、4当量)およびCH3 OCH2 Cl
(0.34ml、2当量)を加え室温にし、1時間後エ
ーテルで希釈した。水性1N塩酸、水性NaHCO3
飽和食塩水の順に洗浄した後エーテル層を分離し、無水
硫酸マグネシウムで乾燥し、濃縮して目的とする上記
(11)式で表される化合物(746mg)を合成し
た。
Alcohol represented by the above formula (10) (9
73.2 mg) was dissolved in methylene chloride (1.2 ml), and diisopropylethylamine (1.53 ml, 4 equivalents) and CH 3 OCH 2 Cl were added at 0 ° C. under an argon atmosphere.
(0.34 ml, 2 eq) was added to room temperature and after 1 hour diluted with ether. Aqueous 1N hydrochloric acid, aqueous NaHCO 3 ,
After washing with saturated brine in that order, the ether layer was separated, dried over anhydrous magnesium sulfate, and concentrated to synthesize the desired compound (746 mg) represented by the above formula (11).

【0057】 1H−NMR(90MHz) δ=1.00〜1.30(m,6H) 1.57(s,6H) 1.72(s,3H) 1.80(d,J=7.80Hz,3H) 2.05(brs,8H) 3.35(s,3H) 3.25〜3.60(m,4H) 4.00(s,2H) 4.57(s,2H) 4.80(s,1H) 5.00〜5.20(m,3H) 5.30〜5.60(m,1H) 5.92(q,J=7.80Hz,1H) 合成例8 1 H-NMR (90 MHz) δ = 1.00 to 1.30 (m, 6H) 1.57 (s, 6H) 1.72 (s, 3H) 1.80 (d, J = 7. 80 Hz, 3H) 2.05 (brs, 8H) 3.35 (s, 3H) 3.25 to 3.60 (m, 4H) 4.00 (s, 2H) 4.57 (s, 2H) 4. 80 (s, 1H) 5.00 to 5.20 (m, 3H) 5.30 to 5.60 (m, 1H) 5.92 (q, J = 7.80Hz, 1H) Synthesis example 8

【0058】[0058]

【化18】 [Chemical 18]

【0059】上記(11)式で表されるアセタール(7
46mg)をメタノール(12ml)、水(3ml)に
溶解し、室温で硫酸銅(100mg)を加えて撹拌し
た。1時間後、エーテルで希釈し、水、水性NaHCO
3 、飽和食塩水の順に洗浄し、エーテル層を分離し、無
水硫酸マグネシウムで乾燥後濃縮して得た残渣をシリカ
ゲルカラムクロマトグラフィー(展開溶媒、ヘキサン:
エチルエーテル=9:1〜1:1)にて精製し、目的と
する上記(12)式で表される化合物(691.2m
g、合計収率59%)を合成した。
The acetal represented by the above formula (11) (7
46 mg) was dissolved in methanol (12 ml) and water (3 ml), and copper sulfate (100 mg) was added at room temperature and the mixture was stirred. After 1 hour, dilute with ether, water, aqueous NaHCO 3.
3 , washed with saturated saline in this order, the ether layer was separated, dried over anhydrous magnesium sulfate, and concentrated to give a residue, which was subjected to silica gel column chromatography (developing solvent, hexane:
The target compound (691.2 m) represented by the above formula (12) was purified by ethyl ether = 9: 1 to 1: 1).
g, total yield 59%) was synthesized.

【0060】 1H−NMR(90MHz) δ=1.55(s,6H) 1.72(s,3H) 2.15(d,J=7.03Hz,3H) 2.10〜2.15(brm,8H) 3.33(s,3H) 4.00(s,2H) 4.48、4.45(dd,2H) 4.98〜5.20(brm,1H) 5.44(brs,3H) 6.67(q,J=7.03Hz,1H) 9.35(s,1H) 合成例9 1 H-NMR (90 MHz) δ = 1.55 (s, 6 H) 1.72 (s, 3 H) 2.15 (d, J = 7.03 Hz, 3 H) 2.10 to 2.15 ( brm, 8H) 3.33 (s, 3H) 4.00 (s, 2H) 4.48, 4.45 (dd, 2H) 4.98 to 5.20 (brm, 1H) 5.44 (brs, 3H) 6.67 (q, J = 7.03 Hz, 1H) 9.35 (s, 1H) Synthesis example 9

【0061】[0061]

【化19】 [Chemical 19]

【0062】上記(12)式で表されるホルミル体(6
91.2mg)を、0℃冷却下トリメチルシリルニトリ
ル(0.22ml)、シアン化カリウム18クラウン6
エーテルを少量加えた2時間後、反応を完結させ、0℃
冷却下テトラヒドロフラン(10ml)、水性1N塩酸
(2ml)を加えた。20分後エーテルで希釈し、水で
洗浄後エーテル層を分離し、無水硫酸マグネシウムで乾
燥し、濃縮した。これをベンゼン(10ml)に溶解
し、0℃冷却下エチルビニルエーテル(0.25ml)
を加え、パラトルエンスルホン酸を少量加えた。50分
撹拌した後、0℃冷却下エーテルで希釈し、水、水性N
aHCO3 、飽和食塩水の順に洗浄し、エーテル層を分
離し、無水硫酸マグネシウムで乾燥した後、濃縮して得
た残渣をシリカゲルカラムクロマトグラフィー(展開溶
媒、ヘキサン:エチルエーテル=9:1〜1:1)にて
精製し、目的とする上記(13)式で表される化合物
(466mg、合計収率54%)を合成した。
The formyl body (6) represented by the above formula (12)
91.2 mg), trimethylsilyl nitrile (0.22 ml) and potassium cyanide 18 crown 6 under cooling at 0 ° C.
Two hours after adding a small amount of ether, the reaction was completed, and the temperature was 0 ° C.
Tetrahydrofuran (10 ml) and aqueous 1N hydrochloric acid (2 ml) were added under cooling. After 20 minutes, the mixture was diluted with ether, washed with water, the ether layer was separated, dried over anhydrous magnesium sulfate, and concentrated. This was dissolved in benzene (10 ml) and cooled at 0 ° C with ethyl vinyl ether (0.25 ml).
Was added, and a small amount of paratoluenesulfonic acid was added. After stirring for 50 minutes, the mixture was diluted with ether under cooling at 0 ° C., water, aqueous N 2
aHCO 3 and saturated brine were washed in this order, the ether layer was separated, dried over anhydrous magnesium sulfate, and concentrated to obtain a residue, which was subjected to silica gel column chromatography (developing solvent, hexane: ethyl ether = 9: 1 to 1). 1) and the desired compound represented by the above formula (13) (466 mg, total yield 54%) was synthesized.

【0063】 1H−NMR(90MHz) δ=1.25(m,6H) 1.59(brs,6H) 1.72(s,3H) 2.05(brm,11H) 3.35(s,3H) 3.35〜3.99(m,2H) 4.00(s,2H) 4.50(brs,2H) 4.80〜5.20(brm,2H) 5.40〜5.70(brm,1H) 6.48(q,1H) IR(film)cm-1:2968,2926,172
8,1689,1661,1444,1380,126
7,1147,1094,1031,933,879 実施例1
1 H-NMR (90 MHz) δ = 1.25 (m, 6 H) 1.59 (brs, 6 H) 1.72 (s, 3 H) 2.05 (brm, 11 H) 3.35 (s, 3H) 3.35 to 3.99 (m, 2H) 4.00 (s, 2H) 4.50 (brs, 2H) 4.80 to 5.20 (brm, 2H) 5.40 to 5.70 ( brm, 1H) 6.48 (q, 1H) IR (film) cm −1 : 2968, 2926, 172
8, 1689, 1661, 1444, 1380, 126
7, 1147, 1094, 1031, 933, 879 Example 1

【0064】[0064]

【化20】 [Chemical 20]

【0065】アルゴン雰囲気下、ヘキサメチルジヒラザ
ン〔NH(TMS)2 〕(0.087ml)とテトラヒ
ドロフラン(2ml)の混合液中に、0℃冷却下ノルマ
ルブチルリチウム(0.23ml、9.5当量)を徐々
に加えた。0℃冷却下30分撹拌した後、60℃にて加
熱還流しながら、アリルクロリド(21.1mg)をテ
トラヒドロフラン(2ml)に溶解したものを2時間か
けてゆっくりと滴下した。これをNH4 Clでクエンチ
し、エーテルで抽出し、飽和食塩水で洗浄し、エーテル
を分離し、無水硫酸マグネシウムで乾燥後濃縮して得た
残渣をシリカゲルカラムクロマトグラフィー(展開溶
媒、ヘキサン:エチルエーテル=9:1〜1:1)にて
精製し、目的とする上記(14)式で表される化合物
(10.7mg、合計収率62%)を得た。
Under an argon atmosphere, a mixture of hexamethyldihirazane [NH (TMS) 2 ] (0.087 ml) and tetrahydrofuran (2 ml) was cooled to 0 ° C. and normal butyllithium (0.23 ml, 9.5 equivalents) was added. ) Was gradually added. After stirring for 30 minutes under cooling at 0 ° C., a solution of allyl chloride (21.1 mg) in tetrahydrofuran (2 ml) was slowly added dropwise over 2 hours while heating and refluxing at 60 ° C. This was quenched with NH 4 Cl, extracted with ether, washed with saturated brine, the ether was separated, dried over anhydrous magnesium sulfate, and concentrated to give a residue, which was then subjected to silica gel column chromatography (developing solvent, hexane: ethyl). The product was purified with ether = 9: 1 to 1: 1) to obtain the desired compound represented by the above formula (14) (10.7 mg, total yield 62%).

【0066】(上記(14)式の化合物は上記一般式
(A)で表される化合物の1つである。) 1H−NMR(90MHz) δ=1.25(m,6H) 1.47(s,3H) 1.56(brs,6H) 1.95(d,J=7Hz,3H) 2.00(brs,8H) 2.16(brs,2H) 3.36(d,J=3Hz,3H) 3.40〜3.80(q,2H) 4.52、4.63(dd,2H) 4.80〜5.40(brm,3H) 5.70(m,2H) 6.12(q,1H) 実施例2
(The compound of the above formula (14) is one of the compounds represented by the above general formula (A).) 1 H-NMR (90 MHz) δ = 1.25 (m, 6H) 1.47 (S, 3H) 1.56 (brs, 6H) 1.95 (d, J = 7Hz, 3H) 2.00 (brs, 8H) 2.16 (brs, 2H) 3.36 (d, J = 3Hz) , 3H) 3.40 to 3.80 (q, 2H) 4.52, 4.63 (dd, 2H) 4.80 to 5.40 (brm, 3H) 5.70 (m, 2H) 6.12 (Q, 1H) Example 2

【0067】[0067]

【化21】 [Chemical 21]

【0068】上記(14)式で表される環化シアノヒド
リンエーテル体(201mg)をテトラヒドロフラン
(2ml)、80%酢酸に溶解し、室温で撹拌した。2
7時間後エーテルで希釈し、2%水性NaOHで強く洗
浄した。シアンヒドリンがケトンにもどった後、水、飽
和食塩水で洗浄し、エーテル層を分離し、無水硫酸マグ
ネシウムで乾燥後、濃縮して得られた残渣をシリカゲル
カラムクロマトグラフィー(展開溶媒、ヘキサン:エチ
ルエーテル=9:1〜1:1)にて精製し、目的とする
上記(15)式で表される化合物(45.6mg、合計
収率25%)を得た。
The cyclized cyanohydrin ether compound (201 mg) represented by the above formula (14) was dissolved in tetrahydrofuran (2 ml) and 80% acetic acid, and the mixture was stirred at room temperature. Two
After 7 hours it was diluted with ether and washed vigorously with 2% aqueous NaOH. After the cyanohydrin returned to the ketone, it was washed with water and saturated brine, the ether layer was separated, dried over anhydrous magnesium sulfate, and concentrated. The residue obtained was purified by silica gel column chromatography (developing solvent, hexane: ethyl ether). = 9: 1 to 1: 1) to obtain the desired compound represented by the above formula (15) (45.6 mg, total yield 25%).

【0069】(上記(14)式および上記(15)式の
化合物は上記一般式(A)で表わされる化合物の1つで
ある。) 1H−NMR(500MHz) δ=1.50(s,3H) 1.66(s,3H) 1.67(s,3H) 2.00〜2.15(brs,8H and d,J=7.14Hz, 3H) 3.20(ABq,J=14.62Hz,2H) 3.35(s,3H) 4.50(d,J=6.59Hz,1H) 4.60(d,J=6.53Hz,1H) 4.80(brm,2H) 5.55(ABq,2H) 6.75(q,J=7.36Hz,1H) IR(film)cm-1:3380,2920,1658,1440, 1383,1290,1261,1214, 1149,1094,1042,920 参考例1
(The compounds of the above formulas (14) and (15) are one of the compounds represented by the above general formula (A).) 1 H-NMR (500 MHz) δ = 1.50 (s, 3H) 1.66 (s, 3H) 1.67 (s, 3H) 2.00 to 2.15 (brs, 8H and d, J = 7.14 Hz, 3H) 3.20 (ABq, J = 14. 62 Hz, 2H) 3.35 (s, 3H) 4.50 (d, J = 6.59 Hz, 1H) 4.60 (d, J = 6.53 Hz, 1H) 4.80 (brm, 2H) 5. 55 (ABq, 2H) 6.75 (q, J = 7.36Hz, 1H) IR (film) cm -1 : 3380, 2920, 1658, 1440, 1383, 1290, 1261, 1214, 1149, 1094, 1042. 920 Reference example 1

【0070】[0070]

【化22】 [Chemical formula 22]

【0071】常法により精製したヨウ化銅(45mg)
にアルゴン雰囲気下エチルエーテル(1ml)を加え、
−78℃冷却下メチルリチウム(0.45ml、1.0
5当量)を加えた。0℃に昇温後、30分撹拌し、再び
−78℃に冷却し、これに上記(15)式で表されるメ
トキシメチルエーテル(45.6mg)をエチルエーテ
ル(0.2ml)に溶解したものをゆっくり滴下した。
1時間後、水性NH4 Clでクエンチし、エーテルで抽
出し、飽和食塩水で洗浄した。エーテル層を分離し、無
水硫酸マグネシウムで乾燥後濃縮して得た残渣をシリカ
ゲルカラムクロマトグラフィー(展開溶媒、ヘキサン:
エチルエーテル=19:1)にて精製し、目的とする上
記(J)式で表される化合物(7.3mg、合計収率2
1.4%)を得た。
Copper iodide (45 mg) purified by a conventional method
Ethyl ether (1 ml) was added under argon atmosphere,
Methyllithium (0.45 ml, 1.0
5 eq.) Was added. After the temperature was raised to 0 ° C., the mixture was stirred for 30 minutes, cooled again to −78 ° C., and methoxymethyl ether (45.6 mg) represented by the above formula (15) was dissolved in ethyl ether (0.2 ml). The thing was dripped slowly.
After 1 hour, it was quenched with aqueous NH 4 Cl, extracted with ether and washed with saturated brine. The ether layer was separated, dried over anhydrous magnesium sulfate, and concentrated to obtain a residue, which was then subjected to silica gel column chromatography (developing solvent, hexane:
Purification with ethyl ether = 19: 1), and the desired compound represented by the above formula (J) (7.3 mg, total yield 2)
1.4%) was obtained.

【0072】(上記(15)式の化合物は上記一般式
(I)で表される化合物のうちの1つである。) 1H−NMR(300MHz) δ=1.08(d,J=6.87Hz,6H) 1.46(s,3H) 1.72(s,3H) 1.77(s,3H) 2.10(brs,8H) 2.67(sept,1H) 3.15(s,2H) 4.94(t,J=6.87Hz,1H) 5.00(t,J=6.31Hz,1H) 5.88(d,J=11.88Hz,1H) 6.21(d,J=11.88Hz,1H) 参考例2
(The compound of the above formula (15) is one of the compounds represented by the above general formula (I).) 1 H-NMR (300 MHz) δ = 1.08 (d, J = 6) .87 Hz, 6 H) 1.46 (s, 3 H) 1.72 (s, 3 H) 1.77 (s, 3 H) 2.10 (brs, 8 H) 2.67 (sept, 1 H) 3.15 (s , 2H) 4.94 (t, J = 6.87 Hz, 1H) 5.00 (t, J = 6.31 Hz, 1H) 5.88 (d, J = 11.88 Hz, 1H) 6.21 (d , J = 11.88 Hz, 1H) Reference Example 2

【0073】[0073]

【化23】 [Chemical formula 23]

【0074】アルゴン雰囲気下、上記(J)式で表され
るケトン体(137mg,0.48mmol)の乾燥ト
ルエン2.5ml溶液に、−70℃の冷媒浴上撹拌しな
がら、水素化ジイソブチルアルミニウムの1Mトルエン
溶液0.6mlを滴下した。1時間後、原料の消失を確
認し、0.25mlの水を加え、浴をはずしよく撹拌し
た。無水硫酸マグネシウムで乾燥後、撹拌し、濾過後、
濃縮して得た残渣をシリカゲルカラムクロマトグラフィ
ー(展開溶媒、n−ヘキサン:酢酸エチル=12:1)
にて精製し、目的とするザルコフィトールA(125m
g,88%)を得た。
Under an argon atmosphere, 2.5 ml of a solution of the ketone body (137 mg, 0.48 mmol) represented by the above formula (J) in dry toluene was stirred on a refrigerant bath at -70 ° C. while stirring for diisobutylaluminum hydride. 0.6 ml of 1M toluene solution was added dropwise. After 1 hour, the disappearance of the raw materials was confirmed, 0.25 ml of water was added, the bath was removed, and the mixture was stirred well. After drying over anhydrous magnesium sulfate, stirring and filtering,
The residue obtained by concentration is subjected to silica gel column chromatography (developing solvent, n-hexane: ethyl acetate = 12: 1).
Purified at the desired sarcophytol A (125m
g, 88%).

【0075】[0075]

【発明の効果】本発明の化合物は、抗発癌プロモーター
作用及び抗腫瘍作用を有するザルコフィトールAの合成
中間体として、極めて有用である。
INDUSTRIAL APPLICABILITY The compound of the present invention is extremely useful as a synthetic intermediate of sarcophytol A having an anticarcinogenic promoter action and an antitumor action.

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.5 識別記号 庁内整理番号 FI 技術表示箇所 C07C 309/66 9160−4H 309/73 9160−4H C07F 7/18 A 8018−4H ─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 5 Identification code Internal reference number FI Technical display location C07C 309/66 9160-4H 309/73 9160-4H C07F 7/18 A 8018-4H

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】 下記一般式(I) 【化1】 〔上記一般式(I)中で、R1 は水素原子、1−アルコ
キシアルキル基、−SO 2 4 (R4 は炭素数1〜4の
アルキル基または炭素数1〜4のアルキル基で置換され
ていてもよいフェニル基を表す。)または−SiR5
6 7 (R5 ,R 6 ,およびR7はそれぞれ独立して炭
素数1〜4のアルキル基またはフェニル基を表す。)を
表し、R2 およびR3 はそれぞれ独立して−CNまたは
−OR8 (R8 は水素原子、1−アルコキシアルキル基
またはトリメチルシリル基を表す。)を表すが、R2
よびR3 が一緒になって酸素原子を表してもよい。な
お、R 1 が−SO2 4 を表すときは、R2 およびR3
は一緒になって酸素原子を表す。〕で表される環状テル
ペン類。
1. The following general formula (I):[In the above general formula (I), R1Is a hydrogen atom, 1-alco
Xyalkyl group, -SO 2RFour(RFourHas 1 to 4 carbon atoms
Substituted with an alkyl group or an alkyl group having 1 to 4 carbon atoms
Represents a phenyl group which may be present. ) Or -SiRFiveR
6R7(RFive, R 6, And R7Each independently charcoal
It represents an alkyl group having a prime number of 1 to 4 or a phenyl group. )
Represent, R2And R3Are each independently -CN or
-OR8(R8Is a hydrogen atom, 1-alkoxyalkyl group
Alternatively, it represents a trimethylsilyl group. ), But R2Oh
And R3May together represent an oxygen atom. Na
Oh, R 1Is -SO2RFourTo represent R2And R3
Together represent an oxygen atom. ] Cyclic tell represented by
Pens.
JP21110691A 1991-08-22 1991-08-22 Cyclic terpene Pending JPH0551335A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP21110691A JPH0551335A (en) 1991-08-22 1991-08-22 Cyclic terpene

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP21110691A JPH0551335A (en) 1991-08-22 1991-08-22 Cyclic terpene

Publications (1)

Publication Number Publication Date
JPH0551335A true JPH0551335A (en) 1993-03-02

Family

ID=16600513

Family Applications (1)

Application Number Title Priority Date Filing Date
JP21110691A Pending JPH0551335A (en) 1991-08-22 1991-08-22 Cyclic terpene

Country Status (1)

Country Link
JP (1) JPH0551335A (en)

Similar Documents

Publication Publication Date Title
US5089625A (en) Substituted cyclic kentones, substituted cyclic enones
WO2004026224A2 (en) Process for preparing prostaglandin derivatives and starting materials for the same
JPH0551335A (en) Cyclic terpene
JP4120925B2 (en) Copper complex and method for producing copper-containing thin film using the same
US5254708A (en) Substituted cyclic ketones, substituted cyclic enones, and process for producing the same
JPH0561268B2 (en)
JPH0551342A (en) Chain terpene
US5231208A (en) Substituted cyclic ketones, substituted cyclic enones, and process for producing the same
US5245085A (en) Substituted-acyclic terpene compound
US5227505A (en) Substituted cyclic ketones, substituted cyclic enones, and process for producing the same
JPH078815B2 (en) Optically Active 2-Methylenecyclopentanone Derivatives, Intermediates Thereof, and Their Production Process
JP3565587B2 (en) Novel synthesis of 15-hydroxymilbemycin derivatives
US5304661A (en) Substituted-acyclic terpene compound
EP0462616A2 (en) Conjugated diene compounds, process for producing these compounds and use thereof
JP2836117B2 (en) Method for producing optically active tertiary allyl alcohol
WO1991008186A1 (en) Substituted open-chain terpene compound
JPH0112757B2 (en)
JPH04352738A (en) Optically active chain terpenes
JPH04283533A (en) Chain terpenes
JPH03170449A (en) Chain terpenes having conjugated diene
EP0455822A1 (en) Open-chain terpene compound
JPH083177A (en) Production of ene-yne compound in the presence of lewis acid
JPH0714893B2 (en) Process for producing optically active cyclopentenone derivative
JPS60260537A (en) Preparation of unsaturated carboxylic acid ester
JPH0257549B2 (en)